CalciMedica is trading 7.49% higher at $2.01 in pre-market amid stronger biotech-sector sentiment, with no definitive company-specific catalyst identified for September 23, 2026. - XBI is up 2.61% pre-market, supported by several positive industry headlines. - The latest company announcement located was its September 8 investor-conference participation notice. - Recent reporting focused on restored Nasdaq compliance, not a new overnight development.